IG vs ID Bitter Administration
NCT03985865 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2019-06-14
Summary
We want to investigate whether bitter compounds, denatonium benzoate and quinine hydrochloride, have a distinct effect on gastrointestinal hormone release after infusion into the stomach or duodenum. Furthermore, we want to observe an effect on hunger sensations and hedonic food intake. Moreover, we suggest somatostatin as a driving factor for decreased motilin and ghrelin release after intragastric administration.
Conditions
Interventions
- DRUG
-
Intragastric quinine hydrochloride
A nasogastric feeding tube was positioned into the stomach, and checked with a pH strip. 10 µmol of quinine hydrochloride per kg body weight was administrated into the stomach.
- DRUG
-
Intragastric denatonium benzoate
A nasogastric feeding tube was positioned into the stomach, and checked with a pH strip. 1 µmol of denatonium benzoate per kg body weight was administrated into the stomach.
- DRUG
-
Intragastric placebo
A nasogastric feeding tube was positioned into the stomach, and checked with a pH strip. 0.1 ml of water (placebo) per kg body weight was administrated into the stomach.
- DRUG
-
Intraduodenal quinine hydrochloride
A nasogastric feeding tube was positioned into the duodenum, and checked with fluoroscopy. 10 µmol of quinine hydrochloride per kg body weight was administrated into the duodenum.
- DRUG
-
Intraduodenal denatonium benzoate
A nasogastric feeding tube was positioned into the duodenum, and checked with fluoroscopy. 1 µmol of denatonium benzoate per kg body weight was administrated into the duodenum.
- DRUG
-
Intraduodenal placebo
A nasogastric feeding tube was positioned into the duodenum, and checked with fluoroscopy. 0.1 ml of water (placebo) per kg body weight was administrated into the duodenum.
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Jan Tack · UZ Leuven
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-03-02
- Primary Completion
- 2018-05-07
- Completion
- 2018-05-07
Countries
- Belgium
Study Locations
More Related Trials
-
Effect of Increased Free Fatty Acids on Leptin Function
NCT01520454 ·Status: COMPLETED ·Phase: NA
-
Mass Balance of Orally Administered [14C] (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one
NCT06230900 ·Status: COMPLETED ·Phase: NA
-
Postprandial Hemodynamics
NCT01027507 ·Status: COMPLETED
-
Gastric and Intestinal Satiation in Obese and Normal Weight Healthy People
NCT01456572 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance
NCT00134290 ·Status: COMPLETED ·Phase: PHASE4
-
High-fat Overfeeding, Hepatokines and Appetite Regulation
NCT03369145 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Leptin Administration During Fasting
NCT00140205 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolic Effect of New Foods Through Gut-brain Axis
NCT01851304 ·Status: COMPLETED ·Phase: NA
-
Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate
NCT00999297 ·Status: COMPLETED ·Phase: NA
-
Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin
NCT00694512 ·Status: COMPLETED ·Phase: NA
-
Dose Response Relationship Between Fat Ingestion and Metabolism
NCT05906342 ·Status: COMPLETED ·Phase: NA
-
Gut Hormone LEAP2 in Metabolism and Eating Behaviour: Fixed Meal Testing
NCT06013592 ·Status: RECRUITING ·Phase: NA
-
Metabolic Differences of an Oral and Intravenous Dose of 3-hydroxybutyrate (3-OHB).
NCT03935841 ·Status: COMPLETED ·Phase: NA
-
Search for Biological Markers of Orosensory Perception of Fatty Acids in Healthy Subjects and Possible Modifications in Patients With Type 2 Diabetes and in Obese Non-diabetic Patients.
NCT02028975 ·Status: COMPLETED ·Phase: NA
-
Use of Indirect Calorimetry in Obesity
NCT03233568 ·Status: COMPLETED
-
Alternating Energy Intake and Blood Fat Content After a Meal
NCT04894526 ·Status: UNKNOWN ·Phase: NA
-
Ginger Capsules for the Chronic Treatment of Obesity
NCT02742194 ·Status: UNKNOWN ·Phase: PHASE2
-
Ketone Production With Acute Caffeine Intake
NCT02694601 ·Status: COMPLETED ·Phase: NA
-
Molecular and Hormonal Responses to Diet-Induced Insulin Resistance
NCT03879187 ·Status: COMPLETED ·Phase: NA
-
Postprandial Profiles of Metabolites and Appetite-regulating Hormones in Plasma and Cerebrospinal Fluid
NCT06115304 ·Status: RECRUITING ·Phase: NA
-
Two Different Dietary Approaches in Body Composition
NCT06139562 ·Status: COMPLETED ·Phase: NA
-
Effect of High and Low Glycemic Index Foods on Post Meal Pulse and Blood Pressure
NCT04910828 ·Status: UNKNOWN ·Phase: NA
-
VLDL-triglyceride Under Acute Hyperinsulinaemia
NCT00624104 ·Status: COMPLETED
-
Prolonged Daily Fasting as a Viable Alternative to Caloric Restriction in At-Risk Obese Humans
NCT04259632 ·Status: COMPLETED ·Phase: NA
-
Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers
NCT01779622 ·Status: COMPLETED ·Phase: NA